{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:59:55Z","timestamp":1772848795418,"version":"3.50.1"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>AbobotulinumtoxinA has been investigated for applications beyond facial rhytides, including the treatment of oily skin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The authors sought to investigate the optimal number of units and the duration of abobotulinumtoxinA for the treatment of oily skin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>This randomized, double-blinded, placebo-controlled study included 50 male and female subjects that got either 0, 15, 30, or 45 units of abobotulinumtoxinA injected into their forehead. For the 6 months after treatment, subjects were evaluated for the effectiveness of the treatment in decreasing the oiliness of their skin and the duration of this effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Subjects in the treatment groups that received either 30 or 45 units of neurotoxin experienced a significant reduction in oily skin. This effect was present for the 6-month duration of the study. No treatment-related adverse events were reported during this study, and both subjects and investigators reported a high level of satisfaction with the treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Thirty or 45 units of abobotulinumtoxinA are safe and effective doses in treating oily skin for improved cosmetic appearance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002494","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T01:43:59Z","timestamp":1596851039000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["A Randomized, Double-Blinded Study Evaluating the Safety and Efficacy of AbobotulinumtoxinA Injections for Oily Skin of the Forehead: A Dose\u2013Response Analysis"],"prefix":"10.1097","volume":"47","author":[{"given":"Katarina","family":"Kesty","sequence":"first","affiliation":[{"name":"Skin Laser and Surgery Specialists of NY and NJ, Hackensack, NJ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Skin Laser and Surgery Specialists of NY and NJ, Hackensack, NJ;"},{"name":"Clinical Professor of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"issue":"Suppl 4","key":"R1-20250731","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0625.2004.00258.x","article-title":"Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors","volume":"13","author":"Kurzen","year":"2004","journal-title":"Exp Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2009.06.040","article-title":"Safety and tolerability of onabotulinumtoxin A in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants","volume":"61","author":"Brin","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 1","key":"R3-20250731","first-page":"44","article-title":"Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin","volume":"39","author":"Goldberg","year":"2013","journal-title":"Dermatol Surg"},{"key":"R4-20250731","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size","volume":"7","author":"Shah","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/asj\/sju150","article-title":"Sebum production alteration after botulinum toxin type A injections for the treatment of forehead rhytides: a prospective randomized double-blind dose-comparative clinical investigation","volume":"35","author":"Min","year":"2015","journal-title":"Aesthet Surg J"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.06.009","article-title":"Regulation of lipid production by acetylcholine signalling in human sebaceous glands","volume":"72","author":"Li","year":"2013","journal-title":"J Dermatol Sci"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:12:24Z","timestamp":1753999944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002494","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}